367 related articles for article (PubMed ID: 25731622)
41. High amyloid-β deposition related to depressive symptoms in older individuals with normal cognition: a pilot study.
Yasuno F; Kazui H; Morita N; Kajimoto K; Ihara M; Taguchi A; Yamamoto A; Matsuoka K; Kosaka J; Kudo T; Iida H; Kishimoto T; Nagatsuka K
Int J Geriatr Psychiatry; 2016 Aug; 31(8):920-8. PubMed ID: 26766490
[TBL] [Abstract][Full Text] [Related]
42. Performance of 11C-Pittsburgh Compound B PET Binding Potential Images in the Detection of Amyloid Deposits on Equivocal Static Images.
Hosokawa C; Ishii K; Kimura Y; Hyodo T; Hosono M; Sakaguchi K; Usami K; Shimamoto K; Yamazoe Y; Murakami T
J Nucl Med; 2015 Dec; 56(12):1910-5. PubMed ID: 26359262
[TBL] [Abstract][Full Text] [Related]
43. Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition.
Park JC; Han SH; Cho HJ; Byun MS; Yi D; Choe YM; Kang S; Jung ES; Won SJ; Kim EH; Kim YK; Lee DY; Mook-Jung I
Alzheimers Res Ther; 2017 Mar; 9(1):20. PubMed ID: 28330509
[TBL] [Abstract][Full Text] [Related]
44. The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction.
Marchant NL; Reed BR; Sanossian N; Madison CM; Kriger S; Dhada R; Mack WJ; DeCarli C; Weiner MW; Mungas DM; Chui HC; Jagust WJ
JAMA Neurol; 2013 Apr; 70(4):488-95. PubMed ID: 23400560
[TBL] [Abstract][Full Text] [Related]
45. Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study.
Ikonomovic MD; Abrahamson EE; Price JC; Hamilton RL; Mathis CA; Paljug WR; Debnath ML; Cohen AD; Mizukami K; DeKosky ST; Lopez OL; Klunk WE
Acta Neuropathol; 2012 Mar; 123(3):433-47. PubMed ID: 22271153
[TBL] [Abstract][Full Text] [Related]
46. Early [(18)F]florbetaben and [(11)C]PiB PET images are a surrogate biomarker of neuronal injury in Alzheimer's disease.
Tiepolt S; Hesse S; Patt M; Luthardt J; Schroeter ML; Hoffmann KT; Weise D; Gertz HJ; Sabri O; Barthel H
Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1700-9. PubMed ID: 27026271
[TBL] [Abstract][Full Text] [Related]
47. Partial-Volume Effect Correction Improves Quantitative Analysis of 18F-Florbetaben β-Amyloid PET Scans.
Rullmann M; Dukart J; Hoffmann KT; Luthardt J; Tiepolt S; Patt M; Gertz HJ; Schroeter ML; Seibyl J; Schulz-Schaeffer WJ; Sabri O; Barthel H
J Nucl Med; 2016 Feb; 57(2):198-203. PubMed ID: 26541776
[TBL] [Abstract][Full Text] [Related]
48. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia.
Rabinovici GD; Jagust WJ; Furst AJ; Ogar JM; Racine CA; Mormino EC; O'Neil JP; Lal RA; Dronkers NF; Miller BL; Gorno-Tempini ML
Ann Neurol; 2008 Oct; 64(4):388-401. PubMed ID: 18991338
[TBL] [Abstract][Full Text] [Related]
49. Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation.
Villeneuve S; Rabinovici GD; Cohn-Sheehy BI; Madison C; Ayakta N; Ghosh PM; La Joie R; Arthur-Bentil SK; Vogel JW; Marks SM; Lehmann M; Rosen HJ; Reed B; Olichney J; Boxer AL; Miller BL; Borys E; Jin LW; Huang EJ; Grinberg LT; DeCarli C; Seeley WW; Jagust W
Brain; 2015 Jul; 138(Pt 7):2020-33. PubMed ID: 25953778
[TBL] [Abstract][Full Text] [Related]
50. Postmortem Pittsburgh Compound B (PiB) binding increases with Alzheimer's disease progression.
Beckett TL; Webb RL; Niedowicz DM; Holler CJ; Matveev S; Baig I; LeVine H; Keller JN; Murphy MP
J Alzheimers Dis; 2012; 32(1):127-38. PubMed ID: 22766739
[TBL] [Abstract][Full Text] [Related]
51. Cerebral Amyloid Angiopathy Pathology and Its Association With Amyloid-β PET Signal.
McCarter SJ; Lesnick TG; Lowe V; Mielke MM; Constantopoulos E; Rabinstein AA; Przybelski SA; Botha H; Jones DT; Ramanan VK; Jack CR; Petersen RC; Knopman D; Boeve BF; Murray ME; Dickson DW; Vemuri P; Kantarci K; Reichard RR; Graff-Radford J
Neurology; 2021 Nov; 97(18):e1799-e1808. PubMed ID: 34504022
[TBL] [Abstract][Full Text] [Related]
52. The correlation between striatal and cortical binding ratio of
Sauerbeck J; Ishii K; Hosokawa C; Kaida H; Scheiwein FT; Hanaoka K; Rominger A; Brendel M; Bartenstein P; Murakami T
Ann Nucl Med; 2018 Jul; 32(6):398-403. PubMed ID: 29730823
[TBL] [Abstract][Full Text] [Related]
53. Positron emission tomography with [18F]flutemetamol and [11C]PiB for in vivo detection of cerebral cortical amyloid in normal pressure hydrocephalus patients.
Leinonen V; Rinne JO; Virtanen KA; Eskola O; Rummukainen J; Huttunen J; von Und Zu Fraunberg M; Nerg O; Koivisto AM; Rinne J; Jääskeläinen JE; Buckley C; Smith A; Jones PA; Sherwin P; Farrar G; McLain R; Kailajärvi M; Heurling K; Grachev ID
Eur J Neurol; 2013 Jul; 20(7):1043-52. PubMed ID: 23398333
[TBL] [Abstract][Full Text] [Related]
54. Evaluating atypical dementia syndromes using positron emission tomography with carbon 11 labeled Pittsburgh Compound B.
Ng SY; Villemagne VL; Masters CL; Rowe CC
Arch Neurol; 2007 Aug; 64(8):1140-4. PubMed ID: 17698704
[TBL] [Abstract][Full Text] [Related]
55. Association of Excessive Daytime Sleepiness With Longitudinal β-Amyloid Accumulation in Elderly Persons Without Dementia.
Carvalho DZ; St Louis EK; Knopman DS; Boeve BF; Lowe VJ; Roberts RO; Mielke MM; Przybelski SA; Machulda MM; Petersen RC; Jack CR; Vemuri P
JAMA Neurol; 2018 Jun; 75(6):672-680. PubMed ID: 29532057
[TBL] [Abstract][Full Text] [Related]
56. Longitudinal Assessment of Amyloid-β Deposition by [18F]-Flutemetamol PET Imaging Compared With [11C]-PIB Across the Spectrum of Alzheimer's Disease.
Hatashita S; Wakebe D; Kikuchi Y; Ichijo A
Front Aging Neurosci; 2019; 11():251. PubMed ID: 31572167
[TBL] [Abstract][Full Text] [Related]
57. Increased Pittsburgh Compound-B Accumulation in the Subcortical White Matter of Alzheimer's Disease Brain.
Wakabayashi Y; Ishii K; Hosokawa C; Hyodo T; Kaida H; Yamada M; Yagyu Y; Tsurusaki M; Kozuka T; Sugimura K; Murakami T
Kobe J Med Sci; 2017 Mar; 62(5):E136-E141. PubMed ID: 28289271
[TBL] [Abstract][Full Text] [Related]
58. Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials.
Liu E; Schmidt ME; Margolin R; Sperling R; Koeppe R; Mason NS; Klunk WE; Mathis CA; Salloway S; Fox NC; Hill DL; Les AS; Collins P; Gregg KM; Di J; Lu Y; Tudor IC; Wyman BT; Booth K; Broome S; Yuen E; Grundman M; Brashear HR;
Neurology; 2015 Aug; 85(8):692-700. PubMed ID: 26208959
[TBL] [Abstract][Full Text] [Related]
59. Apathy correlates with prefrontal amyloid β deposition in Alzheimer's disease.
Mori T; Shimada H; Shinotoh H; Hirano S; Eguchi Y; Yamada M; Fukuhara R; Tanimukai S; Zhang MR; Kuwabara S; Ueno S; Suhara T
J Neurol Neurosurg Psychiatry; 2014 Apr; 85(4):449-55. PubMed ID: 24133289
[TBL] [Abstract][Full Text] [Related]
60. MR-less surface-based amyloid assessment based on 11C PiB PET.
Zhou L; Salvado O; Dore V; Bourgeat P; Raniga P; Macaulay SL; Ames D; Masters CL; Ellis KA; Villemagne VL; Rowe CC; Fripp J;
PLoS One; 2014; 9(1):e84777. PubMed ID: 24427295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
